Evidence map›Paper›PMID 7756172›Full record

ArticleCell growth & differentiation : the molecular biology journal of the American Association for Cancer Research1995

Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells.

J C Cheng, A R Frackelton, E L Bearer, P S Kumar, B Kannan, A Santos-Moore, A Rifai, J Settleman, J W Clark

Abstract read
In one paragraph

Article in Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

J C ChengDivision of Molecular and Cellular Biology, Brown University, Providence, Rhode Island 02908, USA.
A R Frackelton
E L Bearer
P S Kumar
B Kannan
A Santos-Moore
A Rifai
J Settleman
J W Clark
Brown University · US

Funding

MOLECULAR MECHANISMS OF ACTIN DYNAMICS IN PLATELETSR01GM047368 · NIGMS · BROWN UNIVERSITY · PI BEARER, ELAINE L · 1994 to 2003
$1.2M
TUMOR TESTING SYSTEM LABORATORYP30CA013943 · NCI · ROGER WILLIAMS HOSPITAL · PI MAIZEL, ABBY L · 1985 to 1993
–
TYROSINE PHOSPHORYLATION &CONTROL OF CELL GROWTHR01CA039235 · NCI · ROGER WILLIAMS HOSPITAL · PI FRACKELTON, RAYMOND A · 1985 to 1994
–
NCI NIH HHS P30-CA13943NCI NIH HHS R01-CA39235NIGMS NIH HHS GM47368NIGMS NIH HHS R01 GM047368
6 · The paper itself

Abstract

A M(r) 190,000 protein (p190) functions as a GTPase-activating protein (GAP) for Rho and Rac family proteins, which are involved in regulating cytoskeletal actin and membrane ruffling. Tyrosine-phosphorylated p190 also complexes with rasGAP, a regulator of Ras activity, thus possibly linking Ras and Rho pathways. Leukemic cells induced to differentiate along myelomonocytic lineages have increased filamentous actin (as evidenced by phalloidin staining) and extended pseudopodia, and become irregularly shaped and flattened, suggesting altered Rho and Rac function. We, therefore, hypothesized that changes in p190 and its association with rasGAP are an integral part of these shape changes. During phorbol 13-myristate 25-acetate-induced monocytic differentiation of HL60 promyelocytic and RWLeu4 chronic myelogenous leukemic cells, the total amount of p190 decreases rapidly but returns to initial levels by 12 h. In RWLeu4, this was accompanied by commensurate changes in p190 tyrosine phosphorylation and association with p120 type I rasGAP. Association of p190 and type I rasGAP was demonstrated by immunoprecipitation with antibodies to either protein. An additional band at M(r) 100,000 (p100) was detected in immunoprecipitates after 12 h of phorbol 13-myristate 25-acetate treatment. Reverse transcription-PCR and immunoblot analyses suggest that p100 is type II rasGAP, an alternatively spliced product of p120 type I rasGAP. p100 was expressed only in response to direct protein kinase C activators, but all classes of differentiation agents increased tyrosine-phosphorylated p190. Rho and Rac are known to be involved in regulating actin polymerization. The results presented here show that the association of p190 with type I rasGAP parallels increases in actin polymerization and cell adhesion. This suggests a role for p190-rasGAP interactions in phorbol 13-myristate 25-acetate-induced cytoskeletal reorganization.

Indexed as

Guanine Nucleotide Exchange FactorsBase SequenceCell DifferentiationEnzyme ActivationGTPase-Activating ProteinsHumansLeukemia, Myelomonocytic, AcuteMolecular Sequence DataNeoplasm ProteinsNuclear ProteinsPhosphoproteinsPhosphorylationProtein Kinase CProteinsProtein Tyrosine Phosphatasesras-GRF1ARHGAP35 protein, humanARHGAP5 protein, humanGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsNeoplasm ProteinsNuclear ProteinsPhosphoproteinsProtein Kinase CProteinsProtein Tyrosine Phosphatasesras-GRF1RASGRF1 protein, humanras GTPase-Activating ProteinsRepressor ProteinsTetradecanoylphorbol Acetate

Identifiers

PMID7756172
PMCPMC3376091
OpenAlexW2157684383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.